CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
silk surgical scaffolddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02293798
NCT02293798N/ACompleted
CompareCT.gov

Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold

Mark Mofid MD·interventional·Posted Nov 18, 2014·Updated Sep 10, 2019

In Brief

A clinical study evaluating silk surgical scaffold for Mastopexy. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the clinical performance of SERI® Surgical Scaffold to maintain the size of the areola by providing additional soft tissue support after circumferential periareolar mastopexy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMastopexy
CountriesUnited States
CollaboratorsAllergan

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 18, 2014
Enrollment StartAug 1, 2014
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.6 years ago

Interventions

silk surgical scaffolddevice

surgical implant